PD-L1 Biomarker Testing Market by Competitive Landscape, SWOT Analysis, Opportunities and Challenges, Growth by 2022 to 2032


The global PD-L1 biomarker testing market size was valued at US$ 541.6 Mn in 2021 and is expected to exhibit a CAGR of close to 9.4% over the forecast period (2022-2032). Increasing incidence of cancer across the globe is underpinning the need for advanced cancer diagnosis equipment, which is expected to boost the market in the forthcoming years
Information Source:
https://www.futuremarketinsigh....ts.com/reports/pd-l1